Evidence in medulloblastomas
- PMID: 20462836
- DOI: 10.1007/s12094-010-0503-y
Evidence in medulloblastomas
Abstract
Medulloblastoma is the most common infratentorial malignant tumour under 15 years of age. In recent protocols, the patients are stratified for treatment in standard risk or high risk, according to the clinical variables as age, localized or disseminated disease, degree of surgical resection and more recently expected biological behaviour based on retrospective and prospective studies of former samples analyzed. The objectives for future treatments are reduce morbidity without jeopardizing survival.
Similar articles
-
Treatment options for childhood medulloblastoma.Vojnosanit Pregl. 2013 Aug;70(8):773-7. doi: 10.2298/vsp1308773n. Vojnosanit Pregl. 2013. PMID: 24069828 No abstract available.
-
Risk-adapted chemotherapy in childhood medulloblastoma.Expert Rev Anticancer Ther. 2011 May;11(5):771-80. doi: 10.1586/era.10.222. Expert Rev Anticancer Ther. 2011. PMID: 21554052 Review.
-
Cerebellar medulloblastomas in adults.Neurosurg Rev. 1991;14(2):135-40. doi: 10.1007/BF00313039. Neurosurg Rev. 1991. PMID: 1870719 Review.
-
"Primary" leptomeningeal medulloblastoma.Hum Pathol. 2009 Nov;40(11):1661-5. doi: 10.1016/j.humpath.2009.04.024. Epub 2009 Aug 19. Hum Pathol. 2009. PMID: 19695677
-
Clinical management of medulloblastoma in adults.Expert Rev Anticancer Ther. 2004 Oct;4(5):795-802. doi: 10.1586/14737140.4.5.795. Expert Rev Anticancer Ther. 2004. PMID: 15485314 Review.
Cited by
-
Toxicity Reduction after Craniospinal Irradiation via Helical Tomotherapy in Patients with Medulloblastoma: A Unicentric Retrospective Analysis.Cancers (Basel). 2021 Jan 28;13(3):501. doi: 10.3390/cancers13030501. Cancers (Basel). 2021. PMID: 33525583 Free PMC article.
-
Malignant behaviorial characteristics of CD133(+/-) glioblastoma cells from a Northern Chinese population.Exp Ther Med. 2013 Jan;5(1):65-72. doi: 10.3892/etm.2012.747. Epub 2012 Oct 15. Exp Ther Med. 2013. PMID: 23251243 Free PMC article.
-
Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.Clin Transl Oncol. 2014 Jan;16(1):96-101. doi: 10.1007/s12094-013-1048-7. Epub 2013 Apr 30. Clin Transl Oncol. 2014. PMID: 23632814
-
Pulmonary toxicity of craniospinal irradiation using helical tomotherapy.Sci Rep. 2022 Feb 25;12(1):3221. doi: 10.1038/s41598-022-07224-1. Sci Rep. 2022. PMID: 35217707 Free PMC article.